Stora Djumaeva

Stora Djumaeva has extensive work experience in the healthcare industry. Stora recently retired from their role at home in 2021. Prior to that, they served as a Senior Medical Director at Shionogi Inc. from 2018 onwards. Before that, they worked at GSK as the Global Medical Affairs and Patients Relations Leader for Rare Diseases from 2012 to 2018.

From 2007 to 2012, Stora held the position of Medical Director EU, ME&A at Shire Human Genetic Therapies. Stora also served as the EU Medical Director at Shire HGT from 2007 to 2008. Prior to this, they worked at Pfizer Consumer Healthcare as the EU Medical Category Manager from 2004 to 2007.

Stora had positions at Johnson & Johnson, where they served as the European Medical Manager at Johnson & Johnson Consumer Services EAME Ltd. in 2006-2007. Stora also worked at Novo Nordisk as the General Manager for Central Asia and Caucasus from 1993 to 2001.

Stora Djumaeva's education history is as follows:

From 1973 to 1981, Stora Djumaeva attended Tashkent State Medical Institute and obtained a Medical Degree with Honours from the Faculty of Medicine. Stora also pursued Postgraduate Specialist Training in Internal Medicine/Endocrinology during this period.

Between 1999 and 2001, Stora Djumaeva enrolled at Henley Business School, where they earned a Master of Business Administration (MBA) degree.

Starting in an unspecified year, Stora Djumaeva pursued a PhD at the National Research Institute of Endocrinology & Hormones Chemistry. The end year for this degree is mentioned as 1989, though no specific start year is provided in the information.

Finally, from 2004 to 2006, Stora Djumaeva attended Cardiff University / Prifysgol Caerdydd, participating in a Postgraduate Course in Pharmaceutical Medicine. Unfortunately, the degree name for this program is not provided.